LinkedIn facebook twitter youtube
News archive


MPE held a webinar on CAR-T cell treatment with the aim of providing an overview of CAR-T cell treatment in myeloma and to discuss some of the advantages and challenges the myeloma community faces in bringing this treatment to market.

The talk was given by Dr Matteo Carrabba, Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan (Italy).
Find below the recording of this webinar or watch it on our YouTube Channel:




Recent news

» Horizon2020 CARAMBA Myeloma Pipeline information sheet now available in five languages

» The FDA approves the first anti-BCMA CAR-T Cell Therapy for myeloma, idecabtagene vicleucel (Abecma)

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy * for Click to select the duration you give consent until.